DR REDDYS LAB
Location
South Carolina
Founded
2010-04-27
Website
Risk Signals
2 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Nonclassifiable Establishments), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about DR REDDYS LAB
Live alerts from global media, monitored by Business Radar
2024-08-05 (just-food.com)
Nestlé invests further in Indian joint venture with Dr Reddy’s
Nestlé’s Indian arm has invested Rs7.06bn ($83.9m) in its joint venture with pharma group Dr Reddy’s in India.
Read more
2021-06-03 (theprint.in)
Snowman Logistics partners with Dr Reddy's for Sputnik Covid-19 vaccine across India – –
Bengaluru (Karnataka) [India], June 3 (ANI): Integrated temperature-controlled logistics service provider Snowman said on Thursday it has entered in a strategic partnership with Dr Reddy's to...
Read more
2021-05-17 (thenewsminute.com)
Shilpa Medicare ties up with Dr Reddy’s to produce Sputnik V vaccine
Raichur-headquartered Shilpa Medicare has signed a three-year agreement with Dr Reddy’s to produce Sputnik V, the company announced on Monday. Shilpa Medicare’s
Read more
2021-05-12 (economictimes.com)
Dr Reddys Lab: Dr Reddy's launches generic Invanz injection in US market -
We're excited to extend our strategic partnership with Gland Pharma whose hard work, in collaboration with the team at Dr Reddys, has enabled the execution of this launch," Marc Kikuchi, CEO, North America Generics, Dr Reddys said in a release.
Read more
(moneycontrol.com)
Advent gears up for big-bang sale of Bharat Serums and Vaccines
Reports had named Cipla, Zydus Cadila, Dr Reddy's, Carlyle, BPEA EQT and Mylan as other potential suitors for Bharat Serums and Vaccines.
Read more